| Year |
Citation |
Score |
| 2011 |
Borovjagin AV, Dong J, Passineau MJ, Ren C, Lamani E, Mamaeva OA, Wu H, Keyser E, Murakami M, Chen S, MacDougall M. Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells. Plos One. 6: e24281. PMID 22003382 DOI: 10.1371/Journal.Pone.0024281 |
0.425 |
|
| 2010 |
Short JJ, Rivera AA, Wu H, Walter MR, Yamamoto M, Mathis JM, Curiel DT. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Molecular Cancer Therapeutics. 9: 2536-44. PMID 20736345 DOI: 10.1158/1535-7163.Mct-10-0332 |
0.596 |
|
| 2010 |
Matthews QL, Fatima A, Tang Y, Perry BA, Tsuruta Y, Komarova S, Timares L, Zhao C, Makarova N, Borovjagin AV, Stewart PL, Wu H, Blackwell JL, Curiel DT. HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach. Plos One. 5: e11815. PMID 20676400 DOI: 10.1371/Journal.Pone.0011815 |
0.555 |
|
| 2010 |
Nash JE, Appleby VJ, Corrêa SA, Wu H, Fitzjohn SM, Garner CC, Collingridge GL, Molnár E. Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses. Journal of Neurochemistry. 112: 677-90. PMID 19895665 DOI: 10.1111/J.1471-4159.2009.06480.X |
0.519 |
|
| 2009 |
Tang Y, Wu H, Ugai H, Matthews QL, Curiel DT. Derivation of a triple mosaic adenovirus for cancer gene therapy. Plos One. 4: e8526. PMID 20046872 DOI: 10.1371/Journal.Pone.0008526 |
0.69 |
|
| 2008 |
Preuss MA, Glasgow JN, Everts M, Stoff-Khalili MA, Wu H, Curiel DT. Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors. The Open Gene Therapy Journal. 1: 7-11. PMID 19834585 DOI: 10.2174/1875037000801010007 |
0.618 |
|
| 2008 |
Matthews QL, Yang P, Wu Q, Belousova N, Rivera AA, Stoff-Khalili MA, Waehler R, Hsu HC, Li Z, Li J, Mountz JD, Wu H, Curiel DT. Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach. Virology Journal. 5: 98. PMID 18718011 DOI: 10.1186/1743-422X-5-98 |
0.557 |
|
| 2008 |
Tang Y, Le LP, Matthews QL, Han T, Wu H, Curiel DT. Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX. Virology. 377: 391-400. PMID 18570971 DOI: 10.1016/J.Virol.2008.04.023 |
0.633 |
|
| 2008 |
Zhu ZB, Lu B, Park M, Makhija SK, Numnum TM, Kendrick JE, Wang M, Tsuruta Y, Fisher P, Alvarez RD, Zhou F, Siegal GP, Wu H, Curiel DT. Development of an optimized conditionally replicative adenoviral agent for ovarian cancer. International Journal of Oncology. 32: 1179-88. PMID 18497979 DOI: 10.3892/Ijo_32_6_1179 |
0.52 |
|
| 2008 |
Wu H, Curiel DT. Fiber-modified adenoviruses for targeted gene therapy. Methods in Molecular Biology (Clifton, N.J.). 434: 113-32. PMID 18470642 DOI: 10.1007/978-1-60327-248-3_8 |
0.556 |
|
| 2008 |
Saini V, Martyshkin DV, Mirov SB, Perez A, Perkins G, Ellisman MH, Towner VD, Wu H, Pereboeva L, Borovjagin A, Curiel DT, Everts M. An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small (Weinheim An Der Bergstrasse, Germany). 4: 262-9. PMID 18200644 DOI: 10.1002/Smll.200700403 |
0.529 |
|
| 2007 |
Han T, Tang Y, Ugai H, Perry LE, Siegal GP, Contreras JL, Wu H. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy. Virology Journal. 4: 103. PMID 17958897 DOI: 10.1186/1743-422X-4-103 |
0.677 |
|
| 2007 |
Van Houdt WJ, Wu H, Glasgow JN, Lamfers ML, Dirven CM, Gillespie GY, Curiel DT, Haviv YS. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models. Neuro-Oncology. 9: 280-90. PMID 17522331 DOI: 10.1215/15228517-2007-017 |
0.65 |
|
| 2007 |
Tang Y, Han T, Everts M, Zhu ZB, Gillespie GY, Curiel DT, Wu H. Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Gene Therapy. 14: 523-32. PMID 17167498 DOI: 10.1038/Sj.Gt.3302888 |
0.658 |
|
| 2006 |
Matthews QL, Sibley DA, Wu H, Li J, Stoff-Khalili MA, Waehler R, Mathis JM, Curiel DT. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion. Molecular Imaging. 5: 510-9. PMID 17150163 DOI: 10.2310/7290.2006.00029 |
0.519 |
|
| 2006 |
Kangasniemi L, Kiviluoto T, Kanerva A, Raki M, Ranki T, Sarkioja M, Wu H, Marini F, Höckerstedt K, Isoniemi H, Alfthan H, Stenman UH, Curiel DT, Hemminki A. Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3137-44. PMID 16707613 DOI: 10.1158/1078-0432.Ccr-05-2576 |
0.474 |
|
| 2006 |
Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, Chada S, Alvarez RD, Haisma HJ, Dent P, Curiel DT. Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecologic Oncology. 100: 521-32. PMID 16225913 DOI: 10.1016/J.Ygyno.2005.08.042 |
0.563 |
|
| 2005 |
Wu H, Han T, Belousova N, Krasnykh V, Kashentseva E, Dmitriev I, Kataram M, Mahasreshti PJ, Curiel DT. Identification of sites in adenovirus hexon for foreign peptide incorporation. Journal of Virology. 79: 3382-90. PMID 15731232 DOI: 10.1128/Jvi.79.6.3382-3390.2005 |
0.614 |
|
| 2005 |
Särkioja M, Kanerva A, Hakkarainen T, Salo J, Kangasniemi L, Raki M, Ranki T, Wu H, Curiel DT, Hemminki A. 1026. In Vivo Imaging for Evaluation of Adenoviral Capsid Modifications for Systemic Delivery in an Orthotopic Model of Locally Advanced Lung Cancer Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.573 |
0.622 |
|
| 2005 |
Ranki T, Kanerva A, Smitten Kv, Sarkioja M, Kangasniemi L, Raki M, Laakkonen P, Wu H, Curiel DT, Goodison S, Hemminki A. 328. An Orthotopic Murine Model of Advanced Breast Cancer for Imaging and Comparison of Targeting Moieties Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.331 |
0.599 |
|
| 2005 |
Kangasniemi L, Kanerva A, Raki M, Ranki T, Sarkioja M, Kiviluoto T, Stenman U, Alfthan H, Wu H, Curiel DT, Hemminki A. 299. Increasing Gene Transfer and Oncolytic Potency of Adenoviruses in Orthotopic Models of Gastric Cancer Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.302 |
0.604 |
|
| 2004 |
Rein DT, Breidenbach M, Wu H, Han T, Haviv YS, Wang M, Kirby TO, Kawakami Y, Dall P, Alvarez RD, Curiel DT. Gene transfer to cervical cancer with fiber-modified adenoviruses. International Journal of Cancer. Journal International Du Cancer. 111: 698-704. PMID 15252838 DOI: 10.1002/Ijc.20295 |
0.626 |
|
| 2004 |
Wu H, Han T, Lam JT, Leath CA, Dmitriev I, Kashentseva E, Barnes MN, Alvarez RD, Curiel DT. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy Gene Therapy. 11: 874-878. PMID 14999229 DOI: 10.1038/Sj.Gt.3302249 |
0.635 |
|
| 2004 |
Contreras JL, Chaudhuri TR, Stargel AV, Wu H, Smyth C, Bilbao G, Curiel DT, Eckhoff D, Zinn K. IN VIVO QUANTITATIVE NON-INVASIVE BIOLUMINESCENCE IMAGING OF INTRAHEPATIC TRANSPLANTED ISLETS. Transplantation. 78: 439-440. DOI: 10.1097/00007890-200407271-01176 |
0.38 |
|
| 2003 |
Contreras JL, Wu H, Smyth CA, Eckstein CP, Young CJ, Seki T, Bilbao G, Curiel DT, Eckhoff DE. Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets. Transplantation. 76: 252-61. PMID 12865820 DOI: 10.1097/01.Tp.0000066361.02042.Ca |
0.607 |
|
| 2002 |
Wu H, Dmitriev I, Kashentseva E, Seki T, Wang M, Curiel DT. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. Journal of Virology. 76: 12775-82. PMID 12438602 DOI: 10.1128/Jvi.76.24.12775-12782.2002 |
0.613 |
|
| 2002 |
Wu H, Seki T, Dmitriev I, Uil T, Kashentseva E, Han T, Curiel DT. Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency. Human Gene Therapy. 13: 1647-53. PMID 12228019 DOI: 10.1089/10430340260201734 |
0.648 |
|
| 2002 |
Seki T, Dmitriev I, Suzuki K, Kashentseva E, Takayama K, Rots M, Uil T, Wu H, Wang M, Curiel DT. Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enchance hepatotropism in vivo Gene Therapy. 9: 1101-1108. PMID 12140738 DOI: 10.1038/Sj.Gt.3301815 |
0.604 |
|
| 2002 |
Wu H, Nash JE, Zamorano P, Garner CC. Interaction of SAP97 with minus-end-directed actin motor myosin VI. Implications for AMPA receptor trafficking. The Journal of Biological Chemistry. 277: 30928-34. PMID 12050163 DOI: 10.1074/Jbc.M203735200 |
0.53 |
|
| 2001 |
Mehta S, Wu H, Garner CC, Marshall J. Molecular mechanisms regulating the differential association of kainate receptor subunits with SAP90/PSD-95 and SAP97. The Journal of Biological Chemistry. 276: 16092-9. PMID 11279111 DOI: 10.1074/Jbc.M100643200 |
0.543 |
|
| 2000 |
Wu H, Reissner C, Kuhlendahl S, Coblentz B, Reuver S, Kindler S, Gundelfinger ED, Garner CC. Intramolecular interactions regulate SAP97 binding to GKAP. The Embo Journal. 19: 5740-51. PMID 11060025 DOI: 10.1093/Emboj/19.21.5740 |
0.51 |
|
| Show low-probability matches. |